Rare Diseases Drug Library | 罕见病药物库 | MedChemExpress (MCE)
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
MedChemExpress (MCE) | 生产商 | 美国 | 现货 |
性能特点
Rare diseases are an important public-health issue and a challenge for the medical community. Mo
Rare diseases are an important public-health issue and a challenge for the medical community. Most rare diseases are genetic disorders, which are often severely disabling, substantially affect life expectancy, and impair physical and mental abilities. Currently, there are about 7,000 identified rare diseases, together affecting 10% of the population. However, fewer than 6% of all rare diseases have an approved treatment option, highlighting their tremendous unmet needs in drug development. The process of repurposing drugs for new indications, compared with the development of novel orphan drugs, is a time-saving and cost-efficient method resulting in higher success rates, which can therefore drastically reduce the risk of drug development for rare diseases. MCE carefully collects a unique of 1,747 compounds studied in preclinical, clinical trials or approved used in rare diseases treatment. MCE rare diseases drug library is a useful tool for the research of rare diseases. All compounds can provide corresponding indications for rare diseases. 更多产品详情查看:www.medchemexpress.cn/screening/rare-diseases-drug-library.html
Rare Diseases Drug Library | 罕见病药物库 | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供,如您想了解更多关于Rare Diseases Drug Library | 罕见病药物库 | MedChemExpress (MCE)报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途